Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,17S,23S,29S,38S)-17-(4-acetamidobutyl)-41-amino-5,29,38-tris(4-aminobutyl)-2-(3-guanidinopropyl)-23-isobutyl-8-methyl-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazahentetracontan-1-oic acid
ID: ALA4762063
Chembl Id: CHEMBL4762063
PubChem CID: 162659977
Max Phase: Preclinical
Molecular Formula: C55H101N21O16
Molecular Weight: 1312.54
Molecule Type: Unknown
Associated Items: